Author:
Uemura Hirotsugu,De Velasco Marco A.
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Ritchie AWS, deKernion JB (1987) The natural history and clinical features of renal carcinoma. Semin Nephrol 7:131–139
2. Escudier B, Eisen T, Stadler WM, et al (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356:125–134
3. Motzer RJ, Huston TE, Tomczak P, et al (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356:115–124
4. Tykkä H, Oravisto KJ, Lehtonen T, et al (1978) Active specific immunotherapy of advanced renal-cell carcinoma. Eur Urol 4:250–258
5. Tykkä H (1981) Active specific immunotherapy with supportive measures in the treatment of advanced palliatively nephrectomised renal adenocarcinoma. A controlled clinical study. Scand J Urol Nephrol Suppl 63:1–107
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献